ロード中...
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
BACKGROUND: EZH2 acts as an oncogene through canonical pathway EZH2/H3K27Me3 and uncanonical pathway pAkt1/pS21EZH2 in many solid tumors including ovarian cancer. However, the clinical value of EZH2/H3K27Me3 and pAkt1/pS21EZH2 remain unclear. In the current study, we aim to investigate the correlati...
保存先:
| 出版年: | PeerJ |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PeerJ Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7227641/ https://ncbi.nlm.nih.gov/pubmed/32435534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.9052 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|